查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1321652

胞外体研究产品的全球市场

Exosome Research Products
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

胞外体研究产品的全球市场到2030年前将达到11亿美元

在COVID-19后改变的商务环境中，2022年估算为2亿4,310万美元的胞外体研究产品的全球市场，到2030年前将达到11亿美元，在2022年到2030年间将以21.2％的年复合成长率增长。本报告所分析的市场区隔之一的套件&试剂将记录年复合成长率23.4％，到分析期间结束时将达到6亿2,940万美元。考虑疫情后的復苏，设备市场领域今后8年的年复合成长率将修正为20.7％。

美国市场估算为7,260万美元，中国则将以年复合成长率20.5％增长

美国的胞外体研究产品市场在2022年估算为7,260万美元。作为世界第2大经济大国的中国，在2022年～2030年的分析期间中将以年复合成长率20.5％推移，到2030年前将达到1亿9,330万美元的市场规模。其他热门的地区市场有日本和加拿大，在2022年到2030年间将各以18.6％和17％的速度成长。在欧洲市场中，德国预计将以年复合成长率约13％成长。

调查对像企业范例

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen N.V.
  • System Biosciences(SBI)
  • Thermo Fisher Scientific Inc.

目录

第1章 调查手法

第2章 摘要整理

  • 市场概要
  • 主要企业
  • 市场趋势与推动因素
  • 全球市场预测

第3章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲
  • 亚太地区
  • 全球其他地区

第4章 竞争

简介目录
Product Code: MCP21745

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Exosome Research Products Market to Reach $1.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Exosome Research Products estimated at US$243.1 Million in the year 2022, is projected to reach a revised size of US$1.1 Billion by 2030, growing at aCAGR of 21.2% over the period 2022-2030. Kits & Reagents, one of the segments analyzed in the report, is projected to record 23.4% CAGR and reach US$629.4 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 20.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $72.6 Million, While China is Forecast to Grow at 20.5% CAGR

The Exosome Research Products market in the U.S. is estimated at US$72.6 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$193.3 Million by the year 2030 trailing a CAGR of 20.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.6% and 17% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 13% CAGR.

Select Competitors (Total 42 Featured) -

  • AMS Biotechnology Ltd.
  • Bio-Techne
  • Lonza Group AG
  • Miltenyi Biotech
  • Nanosomix
  • Norgen Biotek Corp.
  • NX Pharmagen
  • Qiagen N.V.
  • System Biosciences (SBI)
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Exosome Research Products - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Kits & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Kits & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals & Clinical Testing Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Hospitals & Clinical Testing Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Lung Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Lung Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Breast Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Breast Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Prostate Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Prostate Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Colorectal Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Colorectal Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 24: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 25: World Exosome Research Products Market Analysis of Annual Sales in US$ for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 31: USA 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Canada 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Canada 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Canada 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • JAPAN
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Japan 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Japan 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Japan 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • CHINA
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 45: China 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 47: China 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 48: China Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 49: China 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • EUROPE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Exosome Research Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Europe 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Europe 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Europe 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • FRANCE
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 58: France Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 59: France 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 61: France 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 63: France 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • GERMANY
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Germany 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Germany 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Germany 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • ITALY
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Italy 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Italy 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Italy 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • UNITED KINGDOM
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 76: UK Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 77: UK 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 79: UK 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 81: UK 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Exosome Research Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Component - Kits & Reagents, Instruments and Services - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Rest of World 8-Year Perspective for Exosome Research Products by Component - Percentage Breakdown of Value Sales for Kits & Reagents, Instruments and Services for the Years 2023 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by End-Use - Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Rest of World 8-Year Perspective for Exosome Research Products by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Hospitals & Clinical Testing Laboratories and Academic & Research Institutes for the Years 2023 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Exosome Research Products by Application - Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Rest of World 8-Year Perspective for Exosome Research Products by Application - Percentage Breakdown of Value Sales for Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer and Other Applications for the Years 2023 & 2030

IV. COMPETITION